Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Koninklijke Philips NV's average EPS without NRIGrowth Rate was 12.30% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 19.20% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -0.70% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 10.60% per year.
During the past 13 years, Koninklijke Philips NV's highest 3-Year average EPS without NRI Growth Rate was 177.40% per year. The lowest was -58.70% per year. And the median was 0.70% per year.
Koninklijke Philips NV (OTCPK:RYLPF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Koninklijke Philips NV Earnings per Share (Diluted) Related Terms
Koninklijke Philips NV Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Koninklijke Philips NV's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koninklijke Philips NV Earnings per Share (Diluted) Chart
RYLPF vs ABT, SYK, MDT: Earnings per Share (Diluted) Comparison
For the Medical Devices subindustry, Koninklijke Philips NV's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's PE Ratio distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's PE Ratio falls into.
Koninklijke Philips NV Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Koninklijke Philips NV's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.19
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $1.19 mean?
Koninklijke Philips NV (RYLPF) has a Earnings per Share (Diluted) of $1.19 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Koninklijke Philips NV and its competitors. According to the industry distribution chart, Koninklijke Philips NV ranks #235 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 35.5%.
Is Koninklijke Philips NV's Earnings per Share (Diluted) too high?
Koninklijke Philips NV's current Earnings per Share (Diluted) is $1.19. The Medical Devices & Instruments industry median Earnings per Share (Diluted) is 8.15. Koninklijke Philips NV's value of $1.19 is 85.4% below this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #235 out of 662 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Earnings per Share (Diluted) compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #235 out of 662 companies for Earnings per Share (Diluted). This puts Koninklijke Philips NV in the upper half of its industry. The industry median Earnings per Share (Diluted) is 8.15. Koninklijke Philips NV's value of $1.19 is 85.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current Earnings per Share (Diluted) of $1.19 is 85.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current Earnings per Share (Diluted) is $1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.99, compared to a current price of $27.84 — trading 7.1% above its estimated fair value. The current Earnings per Share (Diluted) is $1.19 and 85.4% below the Medical Devices & Instruments industry median of 8.15. Koninklijke Philips NV's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Earnings per Share (Diluted) is $1.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $27.84 is trading 7.1% above its estimated GF Value™ of $25.99.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
Earnings per Share (Diluted): $1.19
GF Value™: $25.99 vs. price of $27.84 (7.1% above fair value)
Industry Position: 85.4% below the Medical Devices & Instruments median (#235 of 662)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
69GF Score
Get the complete analysis for RYLPF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
